HistoSonics has raised no outside funding. Medical device company. The last valuation is $2.2B, dated Aug 2025.
HistoSonics is privately held and has raised financing through named rounds, including a $100 million round announced alongside a new board appointment.
HistoSonics was founded in 2009, United States.
Medical device company. The company is valued at $2.2B , dated Aug 2025.
No filing has been made.
Medical device company.
Last valuation$2.2BAug 2025
ABC Impact
Founders FundSSunway iLabsThe last valuation is $2.2B.
Lead investors for each round are in the funding timeline.
The closest medical device peers are on the competitors page.
The routes section explains what is realistically available for a company at this stage.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
